(Q43034757)

English

Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy

scientific article published on 4 October 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Torre D

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tambini R

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Cadario F

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Barbarini G

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Moroni M

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Basilico C

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

4 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1579-1585

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs.

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Does hepatitis C virus really have no effect on survival in cases of infection with human immunodeficiency virus?

1 reference

https://api.crossref.org/works/10.1086%2F322611

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43034757&oldid=1978263160"